Histogen Inc reports results for the quarter ended in September - Earnings Summary

Histogen

10/11/2022 23:26

* Histogen Inc  HSTO.OQ  reported a quarterly adjusted loss
of
$1.01​​ per share for the quarter ended in September. The lone
analyst forecast for the quarter was for a loss of $1.26 per
share.
    * Revenue fell 99.2% to $5.00 thousand from a year ago;
analysts
expected zero. 
    * Histogen Inc's reported EPS for the quarter was a loss of
$1.01​.
    * The mean earnings estimate of analysts had risen by
about 30% in
the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Histogen Inc shares had fallen by 18.5% this quarter and
lost 83.5% so far this year.
    * The company reported a quarterly loss of $3.6 million.
    * Wall Street's median 12-month price target for Histogen
Inc is
$17.50 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 1 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
10 at 11:25 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -1.26          -1.01          Beat
 Jun. 30 2022      -1.70          -1.55          Beat
 Mar. 31 2022      -1.50          -0.20          Beat
 Dec. 31 2021      -2.10          -1.40          Beat